Table 1 Basic characteristics of the participants and associations for late and long-term effects

Sex

0.127*

 Women

67.1

291

68.6

247

59.5

44

 Men

32.9

143

31.4

113

40.5

30

Age

< 0.001*

< 0.001*

 19-50 years

23.1

100

27.9

81

13.3

19

23.4

84

21.6

16

 51-64 years

41.3

179

43.4

126

37.1

53

44.8

161

24.3

18

 65-82 years

35.6

154

28.6

83

49.7

71

31.8

114

54.1

40

 Mean age years (SD)

< 0.001**

0.011**

Education

0.199*

0.038*

 Primary school

6.5

28

5.2

15

9.1

13

5.3

19

12.2

9

 Secondary school

30.3

131

29.3

85

32.2

46

29.2

105

35.1

26

 College / University

63.3

247

65.5

190

58.7

84

65.5

235

52.7

36

Household income

0.477*

0.545*

 Low (Less than EUR 40,000)

10.4

45

10.3

30

10.5

15

9.7

35

13.5

10

 Middle (EUR 40,000 to 79,000)

35.1

152

35.9

104

33.6

48

35.9

129

31.1

23

 High (EUR 80,000 or more)

46.4

201

44.5

129

50.3

72

46.8

168

44.6

33

 No reply

8.1

35

9.3

27

5.6

8

7.5

27

10.8

8

 Live alone

22.4

97

24.7

72

17.5

25

0.088*

23.1

83

18.9

14

0.437*

 Live with a partner

72.1

313

68.0

198

80.4

115

0.007*

71.9

259

73.0

54

0.857*

 Live with own children

19.6

85

23.0

67

12.6

18

0.010*

19.7

71

18.9

14

0.874*

 Other

1.6

7

1.7

5

1.4

2

0.580^

1.1

4

4.1

3

0.067*

Place of residence (region)

0.456*

0.210^

 South-East

53.0

230

54.3

158

50.3

72

51.9

187

58.1

43

 South

4.6

20

4.5

13

4.9

7

4.2

15

6.8

5

 West

24.2

105

22.0

64

28.7

41

23.9

86

25.7

19

 Central (Trøndelag)

7.8

34

7.6

22

8.4

12

8.3

30

5.4

4

 North

10.4

45

11.7

34

7.7

11

11.7

42

4.1

3

 Breast

38.7

168

57.4

167

0.7

1

< 0.001*

40.6

146

29.7

22

0.082*

 Gastrointestinal

14.3

62

10.7

31

21.7

31

0.002*

13.3

48

18.9

14

0.211*

 Male genitalia

11.1

48

0.0

–

33.6

48

–

10.0

36

16.2

12

0.120*

 Female genitalia

8.3

36

12.4

36

–

–

–

9.4

34

2.7

2

0.055*

 Lymphoma

9.0

39

6.5

19

14.0

20

0.011*

9.2

33

8.1

6

0.772*

 Head and neck

3.9

17

1.7

5

8.4

12

< 0.001*

4.7

17

0.0

0

0.091^

 Malignant melanoma

4.8

21

4.5

13

5.6

8

0.607*

3.9

14

9.5

7

0.063^

 Lung

3.2

14

2.4

7

4.9

7

0.138^

3.1

11

4.1

3

0.716^

 Sarcoma

3.2

14

4.1

12

1.4

2

0.107^

3.1

11

4.1

3

0.716^

 Leukemia

2.5

11

2.4

7

2.8

4

0.517^

2.5

9

2.7

2

1.000^

 Bone marrow

2.3

10

2.1

6

2.8

4

0.430^

2.2

8

2.7

2

0.682^

 Other cancer sites

13.8

60

10.7

31

20.3

29

0.006*

11.9

43

23.0

17

0.012*

In active cancer treatment

0.244*

0.672*

 Yes

34.6

150

36.4

106

30.8

44

35.0

126

32.4

24

 No

65.4

284

63.6

185

69.2

99

65.0

234

67.6

50

 Fatigue

59.2

257

63.2

184

51.0

73

0.015*

71.4

257

–

–

 Sleep disorder

41.5

180

49.5

144

25.2

36

< 0.001*

50.0

180

–

–

 Hot flashes

39.2

170

49.8

145

17.5

25

< 0.001*

47.2

170

–

–

 Nerve damage (polyneuropathy)

38.0

165

45.7

133

22.4

32

< 0.001*

45.8

165

–

–

 Pain

36.6

159

43.3

126

23.1

33

< 0.001*

44.2

159

–

–

 Decreased muscle strength and mobility

36.4

158

42.6

124

23.8

34

< 0.001*

43.9

158

–

–

 Cognitive challenges

34.3

149

44.3

129

14.0

20

< 0.001*

41.4

149

–

–

 Sexual problems

31.6

137

28.9

84

37.1

53

0.084*

38.1

137

–

–

 Gained weight

27.2

118

33.3

97

14.7

21

< 0.001*

32.8

118

–

–

 Anxiety or depression

22.1

96

24.4

71

17.5

25

0.103*

26.7

96

–

–

 Early menopause

20.7

90

30.9

90

0.0

0

< 0.001*

25.0

90

–

–

 Mouth/tooth-problems and reduced taste

19.4

84

22.3

65

13.3

19

0.025*

23.3

84

–

–

 Urinary tract problems

18.0

78

15.1

44

23.8

34

0.027*

21.7

78

–

–

 Diarrhea

18.0

78

19.9

58

14.0

20

0.129*

21.7

78

–

–

 Constipation

16.6

72

18.6

54

12.6

18

0.116*

20.0

72

–

–

 Lymphedema

15.0

65

17.9

52

9.1

13

0.016*

18.1

65

–

–

 Heart- and lung problems

9.0

39

10.0

29

7.0

10

0.309*

10.8

39

–

–

 Reduced fertility

7.6

33

6.9

20

9.1

13

0.413*

9.2

33

–

–

 Weight loss

6.9

30

5.8

17

9.1

13

0.210*

8.3

30

–

–

 Other late and long-term effects

15.0

65

14.4

42

16.1

23

0.651*

18.1

65

–

–